Unmasking of autoimmune hepatitis in a patient with MS following interferon beta therapy

Neurology

Volumn 66, Issue 12, 2006, Pages 1954-1955

  Pulicken, Mathew ^a   Koteish, Ayman ^a   DeBusk, Karen ^a   Calabresi, Peter A ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON; CELECOXIB; GLATIRAMER; IBUPROFEN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARACETAMOL; PREDNISONE;

ABDOMINAL PAIN; ADULT; ANAMNESIS; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG SUBSTITUTION; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LIVER FUNCTION TEST; MULTIPLE SCLEROSIS; NAUSEA AND VOMITING; PRIORITY JOURNAL;

ADULT; DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; MULTIPLE SCLEROSIS;

EID: 33745897603     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000219764.27182.c7     Document Type: Article

References (6)

1. Tremlett HL, Yoshida EM, Oger J. Liver injury associated with the beta-interferons for MS. Neurology 2004;62:628-631.
2. Duchini A. Autoimmune hepatitis and interferon beta-1a for multiple sclerosis. Am J Gastroenterol 2002;97:767-768.
3. Durelli L, Bongioanni MR, Ferrero B, et al. Interferon treatment for multiple sclerosis: autoimmune complications may be fatal. Neurology 1998;50:570-571.
4. Wallack EM, Callon R. Liver injury associated with the beta-interferons for MS. Neurology 2004;63:1142-1143.
5. Yoshida EM, Rasmussen SL, Steinbrecher UP, et al. Fulminant liver failure during interferon beta treatment of multiple sclerosis. Neurology 2001;56:1416. Erratum in: Neurology 2001;57:2153.
6. Vial T, Descotes J. Clinical toxicity of the interferons. Drug Saf 1994;10:115-150.